Researchers explored a colloidal crystal model to produce specific polymorphs, required for use in materials science and pharmaceuticals. Polymorphs are not mythical, chimeric beasts -- they are ...

Polymorphs are not mythical, chimeric beasts—they are substances with identical chemical compositions but differing crystal structures that also exhibit different physical and chemical properties.

Crystal polymorphism is critically important in the fields of pharmaceuticals and materials science. For instance, a metastable polymorph of an active pharmaceutical ingredient may benefit from ...

Sometimes, compounds crystallize in unexpected ways. This is a problem for drug manufacturers, who need to create consistent products. Scientists are working to understand why substances take on ...

Imagine you’re working at a laboratory that creates pharmaceuticals. You figure out the reactants and the chemistry involved to make a new drug. You design a production line, and your new factory ...

Min Son of Hanol IP & Law reports on a ruling by the Supreme Court of Korea that will make it easier to obtain polymorph patents of known chemicals in the country Patenting polymorphs of crystalline ...

(a) Microscopic image and schematic representation of crystal polymorphs obtained via heteroepitaxial growth (α-phase: green; β-phase: red). Polystyrene particles with a diameter of 860 nm were used ...